Gregory Aurand, CFA joins Noble Capital Markets with coverage responsibilities in Medical Device and Healthcare Services companies. Gregory brings over 25 years of healthcare research analyst experience at Munder Capital Management, Zacks Investment Research, Orbitex Management, Guidepoint Global and Marble Arch Research. He also co-managed healthcare and biotechnology portfolios while at Munder and Orbitex, outperforming peer benchmarks. He has appeared on CNBC and was interviewed by The Wall Street Transcript. At Guidepoint, Gregory developed primary data sets and researched medical technology and therapeutics companies as part of their product efforts to produce market correlative healthcare data. His coverage in healthcare has encompassed a broad spectrum of large-, mid- and small-cap situations with a focus in medical technology. He has also extensively covered pharmaceuticals, biopharmaceuticals, healthcare facilities and services, and health information technology companies. Gregory received his Bachelor’s degree from Michigan State University and is a Chartered Financial Analyst (CFA) Charterholder. He is a member of the CFA Institute and CFA Society New York.
Senior Research Analyst, Healthcare Services & Medical Devices 25 years of healthcare research analyst experience. Bachelor’s degree from Michigan State University. Chartered Financial Analyst (CFA). Member of the CFA Institute and CFA Society New York.
FINRA licenses 7, 86, 87.